"The research and development expenditures in the December quarter relate to three clinical trials which have completed expensive the clinical stage. Hence, future expenditures will be lower." .... now that clinical stage costs for all 3 trials are out of the way future 1/4ly outflows could be more in the 750-950k region. Taking R&D $1.6m coming into account they still have about $2.3mill cash. So will not need to consider CR until end of Financial Year. Having said that A LOT of headline news to come within that period.... BIT likes to get the formalities out of the way before the BIG announcements.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
"The research and development expenditures in the December...
- There are more pages in this discussion • 133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.0¢ |
Change
0.005(11.1%) |
Mkt cap ! $45.11M |
Open | High | Low | Value | Volume |
4.6¢ | 5.2¢ | 4.6¢ | $42.25K | 871.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 155000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.047 |
3 | 131881 | 0.046 |
5 | 214403 | 0.045 |
2 | 255000 | 0.043 |
3 | 52000 | 0.042 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 155000 | 2 |
0.054 | 60000 | 1 |
0.055 | 17000 | 1 |
0.056 | 30000 | 1 |
0.057 | 53617 | 1 |
Last trade - 15.51pm 14/06/2024 (20 minute delay) ? |
|
|||||
Last
5.0¢ |
  |
Change
0.005 ( 8.70 %) |
|||
Open | High | Low | Volume | ||
4.6¢ | 5.1¢ | 4.6¢ | 221683 | ||
Last updated 15.49pm 14/06/2024 ? |
Featured News
BIT (ASX) Chart |